These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 4466653)

  • 1. [Differential diagnosis and differential treatment of carbohydrate tolerance disorders in patients with hyperlipoproteinemia. Behavior of plasma lipids, glucose tolerance, and plasma insulin after glucose load during treatment with clofibrate].
    Bruns W; Rjasanowski I; Wulfert P; Michael R; Knospe S; Hildmann W
    Endokrinologie; 1974 Nov; 64(1):2-12. PubMed ID: 4466653
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of short-term clofibrate on glucose metabolism and insulin secretion in patients with mild maturity-onset diabetes mellitus.
    Ferrari C; Romussi M; Bertazzoni A; Testori GP; Grimaldi MG
    Biomedicine; 1978 Jun; 29(4):133-6. PubMed ID: 556385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertriglyceridemia and carbohydrate intolerance.
    Sailer S
    Horm Metab Res; 1974; Suppl 4():53-6. PubMed ID: 4371578
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of triglyceridemia level on glucose tolerance and insulinemia in subjects with type IV hyperlipoproteinemia.
    Debry G; Drouin P; Mejean L
    Horm Metab Res; 1974 Sep; 6(5):421-2. PubMed ID: 4425070
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum lipids in an ambulary diabetic clientele. Effect of therapy with Atromidin (clofibrate).
    Bergqvist N
    Acta Med Scand; 1970 Mar; 187(3):213-8. PubMed ID: 5444978
    [No Abstract]   [Full Text] [Related]  

  • 6. [Disorders of glucose metabolism and manifestation of diabetes during treatment of endogenous hypertriglyceridemias (author's transl)].
    Vogelberg KH; Dannehl K; Gries FA
    MMW Munch Med Wochenschr; 1981 Nov; 123(48):1862-6. PubMed ID: 6796867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of clofibrate on glucide tolerance in patients with ischemic heart disease and hyperlipoproteinemia].
    Bornemisza P; Csögör I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1978; 30(6):543-6. PubMed ID: 34860
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lipid-lowering effect of bezafibrate in patients with diabetes mellitus and hyperlipidaemia (author's transl)].
    Wahl P; Hasslacher C; Lang PD; Vollmar J
    Dtsch Med Wochenschr; 1978 Aug; 103(31):1233-7. PubMed ID: 668570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clofibrate and carbohydrate metabolism: behavior of blood insulin in patients with blood lipid disorders].
    Ceruso D; Frisina N; Nicita-Mauro V
    Boll Soc Ital Cardiol; 1975; 20(11):1439-47. PubMed ID: 1234442
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clofibrate in the treatment of diabetes mellitus].
    Bornemisza P; Csögör I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1978; 30(4):359-62. PubMed ID: 30153
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of clofibrate therapy on glucose tolerance, insulin secretion and serum lipids in subjects with hyperlipoproteinemia and impaired glucose tolerance. A follow-up study over a five-year period.
    Ratzmann ML; Rjasanowski I; Bruns W; Ratzmann KP
    Exp Clin Endocrinol; 1983 Aug; 82(2):216-21. PubMed ID: 6354731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose and insulin responses are improved in patients with psoriasis during therapy with etretinate.
    Ellis CN; Kang S; Vinik AI; Grekin RC; Cunningham WJ; Voorhees JJ
    Arch Dermatol; 1987 Apr; 123(4):471-5. PubMed ID: 3548599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity, islet function and diabetes mellitus.
    Pfeifer EF
    Horm Metab Res; 1974; Suppl 4():143-52. PubMed ID: 4608433
    [No Abstract]   [Full Text] [Related]  

  • 14. Diabetic lipemia and premature coronary artery disease.
    Lawrence AM
    Ann Clin Lab Sci (1971); 1972; 2(3):233-8. PubMed ID: 4565122
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of halofenate on glucose tolerance in patients with hyperlipoproteinemia.
    Feldman EB; Gluck FB; Carter AC
    J Clin Pharmacol; 1978; 18(5-6):241-8. PubMed ID: 346616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma-insulin response to glucose and circulating serum lipid levels in first-degree relatives of diabetic patients.
    Jakobson T
    Ann Clin Res; 1972 Apr; 4(2):70-7. PubMed ID: 5028067
    [No Abstract]   [Full Text] [Related]  

  • 17. Diabetes, insulin resistance and dyslipidaemia in lipodystrophic HIV-infected patients on highly active antiretroviral therapy (HAART).
    Vigouroux C; Gharakhanian S; Salhi Y; Nguyen TH; Chevenne D; Capeau J; Rozenbaum W
    Diabetes Metab; 1999 Sep; 25(3):225-32. PubMed ID: 10499191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hyperlipoproteinemia -- cause or sequelae of maturity-onset diabetes].
    Bruns W; Rjasanowski I
    Z Gesamte Inn Med; 1975 May; 30(10):57-9. PubMed ID: 1199246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus.
    Ozeki N; Hara K; Yatsuka C; Nakano T; Matsumoto S; Suetsugu M; Nakamachi T; Takebayashi K; Inukai T; Haruki K; Aso Y
    Metabolism; 2009 Oct; 58(10):1470-6. PubMed ID: 19592051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbohydrate metabolism in various types of hyperlipoproteinaemia.
    Romics L; Stützel M; Balázsi I; Varsányi-Nagy M
    Acta Med Acad Sci Hung; 1976; 33(3):225-32. PubMed ID: 1031550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.